Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | CHUK | O15111 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL472769 | 0.93 | CA1 (0.34) | CA1CA2HCRTR1HCRTR2GAA | |
| SCHEMBL472295 | 0.90 | CA1 (0.35) | CA1CA2HCRTR1HCRTR2GAA | |
| SCHEMBL472296 | 0.90 | PDK1 (0.36) | CA1CA2CHUKF2F10 | |
| SCHEMBL472734 | 0.89 | CA1 (0.32) | CA1CA2HCRTR1HCRTR2GAA | |
| SCHEMBL16508607 | 0.89 | CA1 (0.34) | CA1CA2HCRTR1HCRTR2GAA | |
| SCHEMBL472683 | 0.88 | CA1 (0.34) | CA1CA2GAAMAPTHTT | |
| SCHEMBL565285 | 0.88 | CA1 (0.34) | CA1CA2GAAF10MAPT | |
| SCHEMBL472765 | 0.88 | GAA (0.35) | CA1CA2GAAMEN1ALDH1A1 | |
| SCHEMBL472706 | 0.88 | CA1 (0.32) | CA1CA2F2F10 | |
| SCHEMBL472766 | 0.88 | CA1 (0.32) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785485-B2 | Animal ectoparasite-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8785485-B2 | Animal ectoparasite-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-22 | — | — | US | disclosed |
| EP-2412239-B1 | Animal ectoparasite-controlling agent | SUMITOMO CHEMICAL CO (JP) | 2014-04-16 | — | — | EP | disclosed |
| EP-2647285-A2 | Pest control composition | Sumitomo Chemical Company, Limited (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-8507514-B2 | Hydrazide compound and use of the same in pest control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-13 | — | — | US | disclosed |
| EP-2601837-A1 | PEST CONTROL COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2601838-A1 | PEST CONTROL COMPOSITION | Sumitomo Chemical Co., Ltd (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2601836-A1 | PEST CONTROL COMPOSITION | Sumitomo Chemical Company Limited (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2601835-A1 | PEST CONTROL COMPOSITION | Sumitomo Chemical Co., Ltd (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-20130137682-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-30 | — | — | US | disclosed |
| US-20130131083-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20130131083-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20130131117-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20130131115-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20120035218-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035218-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120029038-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120029038-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2412239-A1 | Animal ectoparasite-controlling agent | Sumitomo Chemical Company, Limited (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-20110294840-A1 | HYDRAZIDE COMPOUND AND USE OF THE SAME IN PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130137682-A1 | PEST CONTROL COMPOSITION | H1-4, HRH4, CHRM2 | CA1 989/4885CA2 742/4885HCRTR1 179/4885 |
| US-20130131115-A1 | PEST CONTROL COMPOSITION | HRH2, HRH4, HRH1 | CA1 1176/4885CA2 1092/4885HCRTR1 57/4885 |
| US-20110294840-A1 | HYDRAZIDE COMPOUND AND USE OF THE SAME IN PEST CONTROL | H1-4, H1-2, H1-0 | CA1 1099/4885CA2 670/4885HCRTR1 136/4885 |
| US-20120029038-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | H1-3, HRH4, EEF1A1 | CA1 1006/4885CA2 636/4885HCRTR1 32/4885 |
| US-20130131083-A1 | PEST CONTROL COMPOSITION | H1-4, H1-3, H1-0 | CA1 1406/4885CA2 1614/4885HCRTR1 282/4885 |
| US-20130131117-A1 | PEST CONTROL COMPOSITION | H1-4, H1-0, H1-2 | CA1 1266/4885CA2 1302/4885HCRTR1 225/4885 |
| US-20120035218-A1 | PEST CONTROL COMPOSITION | CTRL, CYP4F3, CYP4B1 | CA1 1471/4885CA2 1171/4885HCRTR1 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.